Onderneming Shin Nippon Biomedical Laboratories, Ltd.
Aandelen
2395
JP3379950003
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1.535 JPY | -0,45% | +3,72% | -9,60% |
Vakgebied
Aantal werknemers: 1 344
Verkoop per activiteit
JPY in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Contract Research Organization
95,4
%
| 16 944 | 95,5 % | 23 924 | 95,4 % | +41,20% |
Medipolis
2,4
%
| 528 | 3,0 % | 601 | 2,4 % | +13,79% |
Other
2,2
%
| 264 | 1,5 % | 549 | 2,2 % | +107,67% |
Translational Research
0,1
%
| 12 | 0,1 % | 16 | 0,1 % | +36,63% |
Verkoop per regio
JPY in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Japan
73,8
%
| 14 657 | 82,6 % | 18 515 | 73,8 % | +26,32% |
United States
15,3
%
| 1 934 | 10,9 % | 3 843 | 15,3 % | +98,76% |
Other
10,9
%
| 1 158 | 6,5 % | 2 733 | 10,9 % | +136,03% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Ryoichi Nagata
CEO | Chief Executive Officer | 65 | 01-09-81 |
Shinji Nitanda
DFI | Director of Finance/CFO | 55 | 01-05-02 |
Terumasa Hirai
CMP | Compliance Officer | - | 01-04-84 |
Shunji Haruta
CTO | Chief Tech/Sci/R&D Officer | - | 01-04-01 |
Ken Takanashi
COO | Chief Operating Officer | 60 | 01-12-02 |
Ichiro Nagata
BRD | Director/Board Member | 38 | 01-04-17 |
Kyomi Nagatoshi
IRC | Investor Relations Contact | - | 01-02-02 |
Hiroyuki Izumi
PRN | Corporate Officer/Principal | - | 01-04-92 |
Masakazu Suda
AUD | Comptroller/Controller/Auditor | 62 | 01-08-90 |
Toshihiko Makino
AUD | Comptroller/Controller/Auditor | - | 01-04-05 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Ichiro Nagata
BRD | Director/Board Member | 38 | 01-04-17 |
Sales & Marketing | 64 | 01-11-02 | |
Ken Takanashi
COO | Chief Operating Officer | 60 | 01-12-02 |
Corporate Officer/Principal | 56 | 01-06-99 | |
Shinji Nitanda
DFI | Director of Finance/CFO | 55 | 01-05-02 |
Hideshi Tsusaki
PRN | Corporate Officer/Principal | 57 | 01-04-96 |
Director/Board Member | 65 | 01-06-15 | |
Director/Board Member | 68 | 01-06-15 | |
Tsuyoshi Hanada
BRD | Director/Board Member | - | 26-06-20 |
Keiko Toya
BRD | Director/Board Member | 60 | 01-06-21 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 0 | 41 632 400 | 20 315 331 ( 48,80 %) | 469 ( 0,001127 %) | 48,80 % |
Participaties
Naam | Aandelen | % | Totale waarde |
---|---|---|---|
WAVE LIFE SCIENCES LTD. 100.00% | 3 901 348 | 100.00% | 24 071 317 $ |
TMS CO., LTD. 3.56% | 1 433 320 | 3.56% | 2 661 231 $ |
400 | 0.00% | 4 012 $ |
Bedrijfsgegevens
Shin Nippon Biomedical Laboratories, Ltd.
St. Luke's Tower, 28/F 8-1 Akashi-cho
104-0044, Tokyo
+81 9 9294 3389
http://www.snbl.co.jpSector
Verkoop per activiteit
Verkoop per regio
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-9,60% | 415 mln. | |
+25,64% | 48,09 mld. | |
+46,90% | 40,62 mld. | |
-3,46% | 40,43 mld. | |
-6,20% | 28,36 mld. | |
+9,17% | 24,89 mld. | |
-20,42% | 19,01 mld. | |
+28,06% | 12,09 mld. | |
+0,19% | 11,88 mld. | |
-1,24% | 11,8 mld. |
- Beurs
- Aandelen
- Koers 2395
- Onderneming Shin Nippon Biomedical Laboratories, Ltd.